ArticleThe Journal of investigative dermatology2022

Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker.

Yuling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.